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Layered double hydroxide-based nanocomposite
scaﬀolds in tissue engineering applications
Burcin Izbudak,†a Berivan Cecen,†bcd Ingrid Anaya,†e Amir K. Miri,bc Ayca BalOzturk *af and Erdal Karaoz*agh
Layered double hydroxides (LDHs), when incorporated into biomaterials, provide a tunable composition,
controllable particle size, anion exchange capacity, pH-sensitive solubility, high-drug loading eﬃciency,
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eﬃcient gene and drug delivery, controlled release and eﬀective intracellular uptake, natural
biodegradability in an acidic medium, and negligible toxicity. In this review, we study potential

DOI: 10.1039/d1ra03978d

applications of LDH-based nanocomposite scaﬀolds for tissue engineering. We address how LDHs

rsc.li/rsc-advances

provide new solutions for nanostructure stability and enhance in vivo studies' success.

1. Introduction
With the development of nanotechnology, biomaterials with
nanoscale features have been commonly designed to be used in
drug delivery and articial matrices.1 The potential of various
nanomaterials, such as carbon nanotubes,2,3 graphene oxide
nanosheets4,5 and nanoclays, (i.e. halloysite nanotubes and
kaolinite nanosheets)6–8 has been extensively investigated.
Among numerous nanomaterials, LDH nanoparticles, nanosized inorganic clay, have attracted the enormous attention of
researchers worldwide due to their advantages, such as
biocompatibility, antigenicity, acceleration of the tissue regeneration, biodegradability, bioactive interface, and controlled
release of drugs. LDHs is a commonly used nanomaterial in
nanomedicine and bioengineering with a unique 2D structure,
controllable particle size,9 and anion exchange capacity,10 pHsensitive solubility, thermal stability,11 chemical stability,12
high-drug loading eﬃciency,13 eﬃcient drug delivery,14 low
toxicity,15 and biocompatibility properties.16 LDHs are 2D
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hydrotalcite compounds having width sizes less than 100 nm,
and their anionic exchange capacity and organic/inorganic
intercalations make them great carriers for drugs and biological agents.17 As a storage matrix, the release of diﬀerent anionic
species into the structure can be controlled by acidic pH.18 They
are commonly shown as [M2+1x M3+x (OH)2] [An]x/n$zH2O,
where divalent cations (M2+) are Mg2+, Fe2+, or Co2+; trivalent
cations (M3+) are Al3+, Fe3+, or Gd3+; and non-framework and
exchangeable anions (An) are Cl, CO32, NO3, etc.19 LDHs
have a layered crystal structure and consist of a positively
charged host layer, since M3+ partially replaces M2+ anions,
alternating with interlayers containing exchangeable anions
hydrated with water molecules19,20 (Fig. 1A). The LDHs'
synthesis methods are co-precipitation, ion exchange in solution, sol–gel, hydrothermal, urea hydrolysis, and the
reconstruction/rehydration method (i.e., memory-impact
method).19,21 The co-precipitation method is the simplest one,
in which basic solutions of LDHs can be easily prepared in high
purity and crystallinity.21,22 The rich-OH ionic groups and
natural positive charges in the structure enable the formation of
3D nano-hybrid structures through interactions with molecules
and nanomaterials. Surface modication can customize for
core, shell, dot-coated, and targeting in the carrier system.23
Diﬀerent characterization methods were used to study LDHs
with biological components, as shown in Fig. 1B and C.15,24 The
three main groups of LDHs used in biomedical applications are
(I) organic agents entrapped between the interlayer of LDHs, (II)
the dispersion of LDHs into a polymeric network, and (III) LDHs
intercalated with biological molecules.25 There have been
numerous studies on these three groups, such as bone tissue
engineering;26 however, there are limited tissue engineering
studies. Here, we introduced the potential applications of LDHs
in tissue engineering applications. We focus on biocompatibility, antibacterial properties, and osteogenic diﬀerentiation
associated with LDHs in tissue engineering, and we discuss
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Fig. 1 (A) The general structure of LDHs. This ﬁgure is reproduced from ref. 19 with permission from Elsevier, copyright 2017. (B) The available
design of LDHs experiments. This ﬁgure is reproduced from ref. 15 with permission from John Wiley and Sons, copyright 2019. (C) Current
research on LDHs, and the existing category of LDH precursors, nanoparticles, hybrids, and biohybrid composites. This ﬁgure is reproduced from
ref. 24 with permission from John Wiley and Sons, copyright 2017.

current challenges and future perspectives. The manuscript is
divided into four sections. First, the bioactivity of LDHs in
diﬀerent systems is discussed. Second, the eﬃciency of LDHs
for antibacterial properties is well explained for various cases.
Third, their applications in bone engineering are shown in
detail. Lastly, future trends and perspectives are discussed. In
this paper, we introduce the recent advances of LDHs for bone
and cartilage tissue-engineered scaﬀolds in regenerative medicine as drug delivery carriers.

2.

Bioactivity of LDHs

Hydrogels can be designed to mimic the extracellular matrix of
so tissues for delivery nanocarriers and cellular scaﬀold
applications in regenerative medicine. In most cases, they only
oﬀer physical support, and they need to be biofunctionalized for

30238 | RSC Adv., 2021, 11, 30237–30252

cell spreading, proliferation, and diﬀerentiation. The toxicity
levels for LDHs have been tested for various cellular components (Table 1). These hydrogels' bioactivation involves the
copolymerization of acrylate functional peptides cross-linked
with poly(ethylene glycol) (PEG) derivatives. Huang et al.27
describe bioactive nanocomposite PEG hydrogel preparation
cross-linked by polydopamine-coated layered double hydroxides (PD-LDHs). The PEG hydrogel with the catechol-rich PDLDH showed tunable mechanical strength, bioactivity and
bioadhesion, self-healing ability and supported the osteogenic
diﬀerentiation of human mesenchymal stem cells.
Bioadhesion is another critical consideration in designing
hydrogels for tissue regeneration. The hydrogels' tight adhesion
potentially leads to better integration with the surrounding
biological tissues, facilitating inltration of bioactive molecules
and cells promoting tissue healing.27 The cellular and

© 2021 The Author(s). Published by the Royal Society of Chemistry
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Toxicity data for LDHs with diﬀerent cell cultures

LDH type/molar
ratio

Size (nm)

Conc. (mg mL1)

Cell types

Assay (test)

Results

Ref.

Mg–Al LDHs 2 : 1

50–100

40

Human embryonic
kidney cells (293T)

MTT

31

Zn–Al LDHs 2 : 1

—

5–150

MTT

Mg–Al LDHs 3 : 1

80–90

20

Mouse broblast cells
(3T3)
Human cervical cancer

Mg–Al LDHs 4 : 1

—

50

MTT

The non-toxic eﬀect, more
than 80% viability aer
three days
90% viability at 100 mg
mL1 concentration
Very low toxicity aer 72 h
treatment
Non-toxic eﬀect

Mg–Al LDHs 3 : 1

—

40

MTT

Non-toxic eﬀect

35

Zn-LDHs

—

25–0.195

MTT

36

Zn-LDHs

—

Zn–Al LDHs 2 : 1

92% viability at 25 mg mL1
concentration
Non-clinical toxicity and
animal demise at 5–500 mg
kg1 dose
Low toxic eﬀect at 800 mg
mL1 concentration
Excellent biocompatibility

MTT

5–500 mg kg1

Breast (MCF-7), HeLa,
and broblast (3T3)
cells
GES-1, MKN45 and
SGC-7901 cells
Monkey kidney (Vero-3)
cells
Rat

Oral toxicity

—

25–800

PC12 cells

MTT

Mg–Al LDHs 3 : 1

100

2–40

MTT

Mg–Al LDHs 3 : 1

50, 100

10–400

Mouse embryonic stem
cells (mESC)
Mouse embryonic stem
cells (mESC)

Mg–Al LDHs 2 : 1

—

1–1000

Human leukemia cells
(HL-60)

MTT

biochemical properties of LDHs were evaluated, in which two
combinations of LDHs (Mg–Al–Cl and Zn–Al–Cl) with diﬀerent
concentrations were tested (Fig. 2A). Standard viability analysis
(MTT) was performed to assess the acceptable range of
concentrations. A range of 0.002–0.2 mg mL1 did not lead to
a half-maximal inhibitory concentration (IC50) value within
24 h. Mg–Al–Cl showed a better cell growth pathway for broblast adhesion when compared to Zn–Al–Cl (Fig. 2B and C). The
eﬀects of the culture media on the shape of LDHs were stated to
be negligible. The results indicate that LDHs guide cellular
adhesion, migration, proliferation and delineate new advances
on the biomaterial area implemented for so tissue bioengineering.26 Baek et al. examined the cytotoxic eﬀects of two
diﬀerent types of LDHs, Mg–Al–CO3, and Mg–Al–Cl, on human
lung alveolar carcinoma epithelial cells (A549) and normal
human lung alveolar epithelial cells (L-132). They prepared
LDHs by the molar ratio of Mg/Al ¼ 2 using the co-precipitation
process. The production of reactive oxygen species (ROS) was
then determined with a cell permeable uorescent probe, 20 ,70 dichlorouorescein diacetate (H2DCFDA). The human lung
alveolar carcinoma epithelial cells (A549) and normal human
lung alveolar epithelial cells (L-132) were treated with LDHs at
concentrations up to 1000 mg mL1 for 72 hours. The stability
and toxicity of LDHs were investigated for the eﬀect of the
proliferation of L-132 and A549 cell lines. Mg–Al–CO3 LDHs
with a size of 200 nm led to signicant ROS in the A549 cell line.
Mg–Al–CO3 LDHs showed higher toxicity in comparison to Mg–
Al–Cl LDHs.28

© 2021 The Author(s). Published by the Royal Society of Chemistry

MTT

No signicant cytotoxicity
at a concentration up to 40
mg mL1
Non-toxic eﬀect

32
33
34

37

38
39
40

41

Choi et al.29 evaluated the toxicity of anionic clay, layered
metal hydroxide nanoparticles, two human lung epithelial cells,
and carcinoma A549 normal L-132 cells. They determined it to
be low tested at the concentrations used (<250 mg mL1) within
48 h in comparison with other inorganic nanoparticles, such as
silica, iron oxide, and carbon nanotubes. Higher concentrations
(250–500 mg mL1) of LDHs for 72 h resulted in an inammatory
response with oxidative stress and membrane damage. Therefore, oxidative stress can be caused depending on the type of
nanoparticle,30 concentration, and exposure time, aﬀecting the
toxicity.
Peng et al. developed the diﬀerent LDHs (Mg–Al, Mg–Fe, Zn–
Al, and Zn–Fe) to apply bone implants. They evaluated the
feasibility of the LDH with biological functional elements as
bone implants, M2+ was chosen for being essential for bone
regeneration, Zn2+ was selected for skeletal development and
antibacterial activity, while Al3+ and Fe3+ for their low toxicity.
Osteoblast-like cells (MC3T3-E1), related to bone growth, and
human umbilical endothelial cells (HUVECs) were investigated
to determine the cytotoxic activity LDHs. LDHs with specic
amounts in the form of extracts or suspensions were treated.
Mg–Al and Mg–Fe LDHs indicated higher cell viability than Zn–
Al and Zn–Fe LDHs. The concentrations of Zn–Al LDHs extract
higher than 1.11 mg mL1 led to signicant toxicity. The
apparent toxicity of Zn–Fe LDHs was observed at an extract
concentration of 123.5 mg mL1. Unlike the extract, Zn–Al and
Zn–Fe LDHs suspensions showed more severe toxicity to
HUVEC and MC3T3-E1 than Mg–Al Mg–Fe LDHs when the
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Fig. 2 (A) The LDHs structure. (B) The eﬀect of two compositions and types of LDHs, Mg–AI–CI and Zn–Al–CI LDHs, on ﬁbroblast adhesion. (C)
The cell morphologies on the LDHs constructs after 24 hours. This ﬁgure is reproduced from ref. 26 with permission from John Wiley and Sons,
copyright 2019.

concentration of their breaks was higher than 41.2 mg mL1.42
The present study evaluated the mechanical properties, as well
as cytotoxicity and antibacterial ability. Zn–Fe LDHs is the most
suitable for a bone implant. It has the highest hardness and
elastic modulus; a mismatch in the elastic modulus between the
bone and the implant would lead to stress shielding, which
causes bone resorption aer surgery.
One major issue of bone implants is the formation of
bacteria lms. Thus, it is essential to engineer the LDHs with
antibacterial potential to allow their osseointegration. It has
been reported in the literature that Zn damages the membrane
and nucleic acid and denatures the bacteria proteins and
enzymes. Therefore, bacteria (E.coli and S. aureus) showed lower
tolerance concentration of Zn–Al LDH and Zn–Fe LDH. Soo et al.
reported that Mg–Al and Zn–Al LDHs at concentrations up to
500 mg mL1 had no toxic eﬀects within 48 hours in various cell
lines and red blood cells.
The ndings revealed that Zn–Al LDHs induced much more
serious membrane damage and hemolysis than Mg–Al LDHs.
Based on these ndings, Mg–Al LDHs in various sizes (50, 100,
200, 350 nm) were tested. Mg–Al LDHs at concentrations up to
500 mg mL1 were treated with A549 cells for 48 hours. While
Mg–Al LDHs of 50 nm in size treated with A549 cell lines were
found to be more toxic than larger nanoparticles, Mg–Al LDHs
in size range from 100 to 200 nm were found to show very low
cytotoxicity. Even LDHs of 50 nm in size, which is a toxic eﬀect
in vitro, did not result in body weight loss or mortality in vivo.
On the other side, in in vivo studies, all LDHs groups did not
cause any mortality or weight loss of 600 mg kg1. The

30240 | RSC Adv., 2021, 11, 30237–30252

assumption that LDHs are attractive biocompatible biomaterials for biological and medical applications has been
conrmed.43
Cunha et al. (2016) assessed the biocompatibility, biointegration, non-immunogenic feature, and antigenicity properties of Mg–Al and Zn–Al LDHs tablets post-implanting
intramuscularly in rat abdominal as it allows to test the activation of the whole immune response in few 7 days and the
rejection process by brous capsule formation in a more
extended period, 28 days through the microcirculation.44 A
stroboscopic LED video-microscopy was used to observe the
micro-circulation patterns of the host tissues around LDHs. The
two types of LDHs had 80–100 nm, and the co-precipitation
process produced them. The sterilized LDHs were implanted
in rats' abdominal walls, and the results showed that LDHs had
appropriate biocompatibility on day 7. Histological tests evaluated the reaction of the LDHs with host tissue postimplantation neo-vascularized connective tissue was observed
around the treated area (Fig. 3). The real-time observation
showed that muscle tissues implanted with Mg–Al and Zn–Al
LDHs support non-immunogenic properties, adequate extracellular matrix remodeling to the desired collagen type wound
healing according to the tablet biophysical composition. This
healing process involves the deposition of collagen and bronectin bers; the Zn–Al LDH tablet sample exhibited
a predominance of collagen type-III bers. Besides, the alkaline
pH buﬀering behavior of the LDHs promoted normal cellular
response as chemotaxis, respiratory activity, and proliferative
capacity of leukocytes; thus, good tissue repair response. These

© 2021 The Author(s). Published by the Royal Society of Chemistry
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Histological images of the implants after 28 days show the ﬁnal tissue reconstruction and the persistence of the implanted LDHs
constructs. This ﬁgure is reproduced from ref. 44 with permission from Springer Nature, copyright 2016.

Fig. 3

results suggest that they can be used in biomedical applications
for drug delivery.44
Nanocomposite-based hydrogels are enhancing the
mechanical and chemical properties of hydrogels and expanding their biomedical applications. When encapsulated with
inorganic nanoparticles, they have shown excellent biocompatibility, stability, and mechanical properties compared to new
hydrogels due to the remarkable physical, chemical, and biological features of inorganic nanoparticles. Wang et al. mixed
LDHs and nanohydroxyapatite (HAp) to develop a porous
nanocomposite hydrogel made of poly(N-isopropyl acrylamide)
(PNIPAm/LDHs/HAp), which showed superior hemocompatibility, enhanced mechanical strength, and reversible swelling/
deswelling properties. These results support that the developed hydrogel embedded with LDHs and HAp has excellent
potential for tissue engineering and clinical practices.45

3.

Antibacterial properties of LDHs

Antibacterial properties in scaﬀolds yield signicant success
and adaptation in clinical applications.46 The antimicrobial
activity of scaﬀolds allows controlling surgical infections and
reducing any antimicrobial agents' injection.47 An ideal implant
should have an antibacterial ability while providing cell

© 2021 The Author(s). Published by the Royal Society of Chemistry

adhesion and proliferation. Metallic ions such as Ag, Zn, Ti, Sr
can be incorporated into scaﬀolds to accelerate tissue regeneration with minimal infections.48 These metallic ions cause ROS
production in antibiotic-resistant bacteria, causing membrane
and DNA damage and inactivating metabolic proteins such as
respiratory enzymes.49 LDHs can decrease the number of
nutrients in the culture media by adsorbing on the surface of
particles. Diﬀerences in the environment's physicochemical
features occur, inhibit bacteria's growth (Fig. 4A). In the
meantime, electrostatic interactions between the cationic LDHs
and negatively charged bacterial surface can cause bacterial
growth inhibition.50
LDHs also show strong ion-exchange potential and porous
structures; for example, Zn ion-based LDHs exhibit strong
antibacterial properties leading to bone implant's fast regeneration.51 Peng et al. have recently reported an alternative
method by preparing Mg–Al, Mg–Fe, Zn–AI, and Zn–Fe LDHs.
Extract and suspension forms of Zn–Al LDHs and Zn–Fe LDHs
displayed a better antibacterial impact on Gram-positive S.
aureus and Gram-negative E. coli compared to the Mg–Al and
Mg–Fe LDHs. Zn–AI and Zn–Fe LDHs into the scaﬀold showed
higher success and potential for the application of antibacterial
implants.42 The bacterial resistance to antibiotics increases over
time. Gohi et al. developed a new organic–inorganic hybrid

RSC Adv., 2021, 11, 30237–30252 | 30241
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Fig. 4 (A) A schematic illustration of an antibacterial-experimental strategy and possible antibacterial mechanism of LDHs. This ﬁgure is

reproduced from ref. 50 with permission from Elsevier, copyright 2020. (B) Eﬀects of CS, Zn–Al LDHs, and CS/Zn–Al LDHs against P. cyclopium
and E. coli. This ﬁgure is reproduced from ref. 52 with permission from MDPI, copyright 2019.

biomaterial consisting of Zn–Al LDHs/chitosan (CS). With the
release of Zn2+ and Al3+ metal ions from Zn–Al LDHs/CS hybrid
biomaterial, an increase of the inhibition zone of 41.6% against
E. coli and almost 100% for Penicillium cyclopium (P. cyclopium)
was observed (Fig. 4B).52 In another study, an antibacterial
environmentally friendly polyurethane (WPU)-based composite

30242 | RSC Adv., 2021, 11, 30237–30252

was synthesized with Zn–Al LDHs, and ZnO, ZnO LDHs have
been reported to inhibit bacteria growth and their proliferation
eﬀectively. The antibacterial eﬀect was assessed for composite
biomaterials against Gram-negative E. coli and Gram-positive S.
aureus. The results show that WPU embedded with ZnAl-LDHs/
ZnO has solid antibacterial potential. The antibacterial activity

© 2021 The Author(s). Published by the Royal Society of Chemistry
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of WPU/Zn–Al LDHs/ZnO composite exists on two mechanisms.
First, ZnO activates intercellular ROS such as hydrogen peroxide
(H2O2) and strengthens oxidizing agents, damaging the bacterial cells. Second, Zn+2 ions in LDHs penetrate the bacterial
membrane while altering the cell membrane's permeability and
causing individual proteins' denaturation.53 In another similar
study, the proliferation of S. cerevisiae, S. aureus, and E. coli has
been severely inhibited by Zn–Ti LDHs and evaluated the sizedependent antibacterial behavior of Zn–Ti LDHs. Ti+3 cations
in Zn–Ti LDHs with a size of 40 nm showed a more active
antibacterial eﬀect than metal oxide and TiO2. Zn–Ti LDHs
killed more than 95% of the bacteria and exhibited excellent
antibacterial action.54
Since silver has antibacterial properties, composite biomaterials have been preferred in many studies. Mehdi et al.
focused on the antibacterial eﬀect of silver and LDHs in the
carboxy-methyl-cellulose (CMC)-based hydrogel. CMC nanocomposites' antibacterial eﬀect includes Mg–Al, Ni–Al, Zn–Al,
and-Al LDHs against E. coli and S. aureus bacteria has been
investigated. Cu–Al LDHs/CMC and Zn–AI LDHs/CMC nanocomposites showed more antibacterial eﬀects than nanocomposites, including Mg–Al Ni–Al LDHs. This is because of Cu
and Zn ions' antibacterial properties released from Cu–Al LDHs/
CMC and Zn–AI LDHs/CMC constructs. The inhibition zone for
Cu–Al LDHs/CMC and Zn–Al LDHs/CMC against E. coli
decreased aer 3 days. On the other hand, they displayed better
potential towards S. aureus and kept their antibacterial impact
for more than 2 weeks.55 Gabriela et al. reported the antibacterial eﬀects on Zn–AI LDH, Ag/Zn–AI LDHs, and AgNP against S.
aureus and E. coli. The superior stability and eﬃcacy of the
antibacterial potential of Ag/Zn–AI LDHs are possibly owing to
the power of the LDHs structure to adsorb microorganisms;
thus, enabling strong interactions with the silver from the
surface.56
Ahmed et al. successfully used Zn for antibacterial properties
of polyaniline (PAn) nanocomposite, including Zn–Al LDHs.
The antimicrobial activity of PAn/Zn–Al LDHs nanocomposites
was assessed against Gram-positive (Staphylococcus aureus),
Gram-negative (Pseudomonas aeruginosa) bacteria, and fungi
(Candida albicans). The results reported that PAn/Zn–Al LDHs
prevented bacteria and fungi from stuck on the surface and
provided antimicrobial eﬀects by growing the ability.57 In
another study, Penicillin G (PNG)-loaded Zn–Al LDHs prepared
to make prolonged antibacterial potential against E. coli. In the
meantime, the released Zn+2 ions from Zn–Al LDHs had an
antibacterial ability by signicantly improving the antibacterial
eﬀect of PNG.58
Jin et al. intercalated an anticancer drug 5-uorouracil/
cyclodextrin (5-FU/CMCD) into a Zn–Al LDH. The drug release
time was prolonged and controlled by the hydrophobic environment of the CMCD cavity and by the durability of the LDH.
Therefore, the release behavior of 5-FU from 5-FU/CMCD-LDH
composite could be modulated by a change in the environmental pH value.1 Other pharmaceutical compounds such as
ibuprofen, fenbufen, and diclofenac have been incorporated
into LDHs and exhibited LDH-based tunable drug delivery
systems' feasibility.1,9,19

© 2021 The Author(s). Published by the Royal Society of Chemistry
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4. Osteogenic diﬀerentiation
properties of LDHs
The bone tissue that forms the skeletal system is protected and
renewed by the proliferation of osteoblasts and osteoclasts. The
primary cells that provide bone formation are osteoblasts,
which allow the shaping of new bone tissue and mineralization
with ECM. Throughout diﬀerent experiments, embryonic stem
cells (ESCs), pluripotent stem cells (PSCs), MSCs, and bone
marrow (BM-MSCs) are commonly used to diﬀerentiate into
osteoblasts.47 Genes that provide osteogenic diﬀerentiation
have many transcription factors and proteins. The primary
transcription factor is runt-related transcription factor 2
(RUNX2), which provides the expression of osteocalcin (OCN),
collagen type 1 (COL1A1), and osteocalcin (OCN) proteins.59
Another specic transcription factor is alkaline phosphatase
(ALP), which measures osteoblasts' ability to mature and
regenerate bone.60 Tissue engineering creates scaﬀolds that can
regenerate bone by stimulating genes, mimicking the bone
structure, and providing osteogenesis.61 Due to its ionic content
and layered structure, LDHs have been recently preferred in
bone scaﬀolds reducing mechanical strength, producing Mg+2,
and forming an alkaline micro-environment (Table 2).62 During
Mg+2 ions released from LDHs, osteogenic cells' integrin
expression is upregulated,63 and Mg+2 ions have a synergistic
eﬀect on stem cells' ALP activity and osteogenesis pathways.64
During osteoclastogenesis, LDHs promote osteoblastic phenotype by up-regulating osteogenic marker genes, RANKL and
OPG. The pathways of signaling in response to LDHs are actualized by osteoblasts.61 In conclusion, LDHs can be considered
a signicant stimulus during osteoclastogenesis and preferred
to repair bone defects.
The microstructure and chemical composition of gelatin/
LDHs/Hap-based scaﬀolds were similar to native bone structures. The gelatin/LDHs/HAp-based scaﬀold's bone regeneration ability was shown in orthopedic and regenerative surgery
for bone healing.65 For signicant bone defects to restore
healthy bone, engineered scaﬀolds should be biocompatible
and support osteogenic diﬀerentiation without causing infection. Dandan et al. successfully prepared a new nanocomposite
scaﬀold by combining Ag-laden MgSrFe LDHs with CS (CS/AgMgSrFe LDH). CS/Ag-MgSrFe nanocomposite scaﬀold was
non-toxic on human bone marrow-derived mesenchymal stem
cells (hBMSCs). The cells showed enhanced spread, proliferation, and adhesion on the scaﬀold. Due to the release of Sr2+
ions from LDHs, ALP RUNX2 and BMP-2 expression increased.
CS/Mg–Fe LDHs were compared with CS/Ag-MgSrFe LDH
nanocomposite scaﬀold, and data indicated that the nanocomposite scaﬀolds containing Ag and Sr elements support
osteogenic diﬀerentiation. Besides, Ag components in LDHs
provided excellent bone formation, which gained antibacterial
activity and kept osteoinductivity (Fig. 5C).66
Heqin et al. utilized a new nanocomposite consisting of PEGbased hydrogel by using polydopamine-coated LDHs (PDLDHs). The catechol-rich PD-LDHs nanosheets not only
possessed strong bioadhesive properties in the aqueous
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Table 2

Review

LDHs major applications for bone regeneration and tissue engineering

LDH type

Application

Cell line/tissue model

Results

Ref.

Mg–Al, Mg–Fe, ZN–Al,
and Zn–Fe LDHs

Bone implantation

MC3T3-E1

42

Mg–Fe LDH

Bone implantation

rBMSCs

Cs/Ag-laden MgSrFe
LDHs

Bone regeneration

hBMSCs

PD-LDHs

Bone regeneration

hMSCs

Mg–Al LDHs

Bone regeneration

rBMSCs and MC3T3-E1

CS/Mg–Al LDHs/PFT-a

Bone regeneration

hBMSCs

Mg–Al and Zn–Al LDHs

Bone regeneration

Preosteoblasts

Vitamin D3 (VD3) LDHHap

Bone regeneration

(PAEU/LDH/hGH)
Adenosine (Ado)-loaded
Mg–Al LDHs

Bone regeneration

HAp containing
scaﬀolds (LHG and
LHGD)
HCT-166 cell lines and
in vivo rat model

Zn–Fe had the highest hardness and
elastic modulus, most suitable avoiding
bone resorption aer surgery.
Mg–Fe LDH lms on titanium increased
the ALP activity, collagen secretion, ECM
mineralization, and proliferation and
osteogenic diﬀerentiation.
ALP, RUNX2 and BMP-2 expression
increased. Ag and Sr elements supported
osteogenic diﬀerentiation and bone
formation.
Increased the mechanical strength,
bioadhesion, spreading and osteogenic
diﬀerentiation of hMSCs.
Mg–Al LDHs and titanium's alkaline
environment regulated the oxidative
stress, proliferation, and ALP activities of
osteoblast cells.
PFT-a induced the GSK3-b/y-cantenin
pathway and showed an enhancing eﬀect
on hBMSC diﬀerentiation.
Enhanced osteocalcin (OCN), RUNX2,
and Osterix (OSX). Reprogramming the
mineralization and osteoclast-osteoblast
fusion.
Increased mechanical strength and
ossication.

Bis-GMA and
TEGDMAwith Mg–Al–F
LDH
Mg–Al LDHs

Dental applications

hDPSCs

Tissue regeneration and
drug release

Calvarial osteoblasts
isolated from mice

Chondrogenic
diﬀerentiation

TMSCs

PAG-PA-PD with Mg–Al
LDHs

environments but also increased the mechanical strength of the
obtained PEG-based hydrogel (Fig. 5A and B). It was seen that
PD-LDHs cross-linked PEG-based nanocomposite hydrogel
enhanced adhesion, spreading, and osteogenic diﬀerentiation
of human derived mesenchymal stem cells (hMSCs). As a result,
they carried out a nanocomposite hydrogel that can have
incredible potency in regenerative medicine and open up a new
way to design PEG-based nanocomposite constructs.67
Loredana et al. have explored the fundamental eﬀects of
uoride ion-doped Mg–Al LDHs into hydrogel scaﬀolds.
Bisphenol-A glycidyl dimethacrylate (Bis-GMA) and tri-ethylene
glycol dimethacrylate (TEGDMA) combined with Mg–Al–F LDH.
The addition of Mg–Al–F LDHs promoted the mechanical
features of the hydrogel resin. Slow uoride release from
hydrogel increased human dental pulp stem cells (hDPSCs) and
ALP activity, an early odontoblastic diﬀerentiation for 28 days.
Considering these results, Mg–Al–F LDHs can be used as
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Osteogenic diﬀerentiation of stem cells
through the activation of the adenosine
a2b receptor. Repaired rat tibia aer six
weeks.
Fluoride release increased the hDPSCs
and ALP activity, an odontoblastic
diﬀerentiation.
High ALP potential and bone nodule,
Mg–Al LDHs supported antiinammatory and osteogenic activity.
Increased mRNA ad protein levels of type
II collagen and SOX9 in TMSCs

70

66

67

63

71

61

73

68

61

62

65

a dental ller for tooth resins.68 In another study, Michelle et al.
developed a guided tissue regeneration membrane suitable for
periodontology. The controlled release of drugs was achieved
from tetracycline and alendronate from Mg–Al LDHs into the
poly(lactic-co-glycolic acid) (PLGA)-based membranes. Calvarial
osteoblasts isolated from mice were incubated with membranes
for ve weeks. A high ALP potential and bone nodule formation
were detected, and Mg-AI LDHs supported anti-inammatory
and osteogenic activity as a bone gra.69
Tan et al. have designed a biomaterial to capture implant
failures to investigate antibacterial and osteogenic activities on
the diﬀerent alkaline microenvironment of titanium surfaceassociated with Mg–Al LDHs. Cellular adhesion, proliferation,
and ALP activities were examined on rat bone marrow mesenchymal stem cells (rBMSCs) and mouse osteoblast cells
(MC3T3-E1) 1,4 and 7 days. They also conrmed that Mg-AI
LDHs and titanium's alkaline environment regulates the
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(A) Schematic illustration of polydopamine coating on LDHs and nanocomposite scaﬀold prepared by using 4-arm thiol-terminated
polyethylene glycol (4-arm PEG-SH) and polydopamine-coated LDHs (PD-LDHs), which can carry biomacromolecules and act as the sealant for
bone fracture. (B) The prepared nanocomposite scaﬀold has a strong sealant function for fractured bone pieces. This ﬁgure is reproduced from
ref. 67 with permission from John Wiley and Sons, copyright 2016. (C) Alizarin Red staining for ECM mineralization of hBMSCs with CS/Mg–Fe,
CS/Ag–MgFe/, CS/MgSrFe, and CS/Ag-MgSrFe scaﬀolds. This ﬁgure is reproduced from ref. 66 with permission from John Wiley and Sons,
copyright 2017. (D) The cranial defect was created, and CS/LDHs-PFTa or CS/LDHs constructs were placed in the cranial defects. (E) After twelve
weeks, the defect region was examined using reconstructing micro-CT images. This ﬁgure is reproduced from ref. 71 with permission from RSC
Pub, copyright 2017.

Fig. 5

© 2021 The Author(s). Published by the Royal Society of Chemistry
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(A) In vivo implantation of gelatin/LDHs/HAp-based scaﬀold for bone tissue engineering application. This ﬁgure is reproduced from ref. 17
with permission from Elsevier, copyright 2017. (B) Schematic hGH loading in LDHs, and nanocomposite hydrogels. This ﬁgure is reproduced from
ref. 74 with permission from RSC Pub, copyright 2015. (C) Schematic representation of Ado-loaded Mg–Fe LDHs preparation and their applications. The developed nanoparticular platform synergistically induces the osteogenic diﬀerentiation of stem cells for healing of extended bone
defects by co-delivering the Ado ligand and ligation stimulator (Mg ion). This ﬁgure is reproduced from ref. 64 with permission from Elsevier,
copyright 2017.

Fig. 6
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oxidative stress, proliferation, and ALP activities of osteoblast
cells.63 In another study, Qianwen et al. produced Mg–Fe LDH
lms on titanium surfaces for challenging tissue implantation.
Biocompatibility, proliferation, and osteoblast diﬀerentiation
of the lms were investigated on rBMSCs. They noticed that
Mg–Fe LDH lms on titanium increased the proliferation and
osteogenic diﬀerentiation, ALP activity, collagen secretion, and
ECM mineralization of rBMSCs, representing the encouraged
applications as hard tissue implant materials.70
p53 has a key rol in bone formation and metabolism.
Scientists have recently reported that decreased p53 function is
associated with bone formation. Pithrin-a (PFT-a) is a chemical inhibitor of p53 that prohibits p53 role for bone formation.72 Yi-Xuan et al. investigated the diﬀerent doses of PFT-a on
the CS/Mg–Al LDHs composite scaﬀolds (CS/Mg–Al LDHs/PFTa) hBMSCs. They claimed that CS/Mg–Al LDHs/PFT-a scaﬀolds
could be a novel strategy with natural bone regeneration functionality. For all that, they emphasized the increased COL1, bcatenin, and p53 by inducing the GSK3b/y-catenin pathway due
to the release of PFT-a. Consequently, PFT-a induced the Wnt/bcatenin pathway and showed an enhancing eﬀect on hBMSC
diﬀerentiation (Fig. 5D and E).71 In another study, the molecular
mechanisms of Mg–Al and Zn–Al LDHs from preosteoblast to
mature osteoblast led to enhanced osteocalcin (OCN), RUNX2,
and Osterix (OSX). Mg–Al LDHs have a keynote regulation on
OSX mRNA levels reprogramming the mineralization and
osteoclast-osteoblast fusion balance with signal molecules.61
Fateme et al. investigated the encapsulation of vitamin D3 on
the gelatin-based scaﬀolds. LDH-HAp was combined with
vitamin D3 to reinforce scaﬀolds. They observed that vitamin
D3 plays a primary function in calcium accumulation, ALP
activity regulation and osteoblastic expression. Reinforcement
with vitamin D3 (VD3) the LDH-HAp into the scaﬀolds
increased the mechanical strength and ossication, mimicking
the mineral/organic structure of the natural bone and VD3
signaling eﬀect. The HAp containing scaﬀolds (LHG and LHGD)
avoided the adverse impacts of burst release, showed less water
uptake, and recrystallized HAp, resulting in more bioactivity in
these scaﬀolds. The more packed structures of LGD and LHGD
lead to a decrease in the degradation rate due to less diﬀusion.73
Narendra et al. have prepared nano-bio hybrid injectable
scaﬀolds (PAEU/LDH/hGH) to reduce the adverse eﬀects of
human growth hormone (hGH) inhibited by their early degradation short half-life. hGH was intercalated in the positively
charged Mg–Al LDHs through an anion exchange technique
(Fig. 6B). The injectable nano-biohybrid scaﬀold showed the
delayed-hGH release diﬀusion by dual-ionic interactions as the
scaﬀolds' pH and temperature sensitivity. Cytotoxicity using
HCT-166 cell lines and in vivo rat model was used to study the
scaﬀolds' biological response.74
Injectable hydrogels loaded with LDHs-hGH may be used
eﬀectively for sustained-hGH delivery to enhance biological
eﬃcaciousness and patient compliance.74 Adenosine (Ado)loaded Mg–Fe LDHs were also embedded within the injectable hydrogel to support the bone defect healing (Fig. 6C). The
dual delivery of Ado and Mg ions from Ado-loaded Mg–Fe LDHs
containing injectable hydrogel supported osteogenic

© 2021 The Author(s). Published by the Royal Society of Chemistry
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diﬀerentiation of stem cells through the synergistic activation
of the adenosine A2b receptor was indicated. Furthermore, the
injectable hydrogel promoted repairing rat tibia bone defects
aer six weeks. The serum hGH concentration remained high
(1 ng mL1) with the LDH-hGH complex and pristine PAEUhGH hydrogel for 1 and 3 days respectively, with a minimal
initial burst release compared with hGH alone; these eﬀects are
mainly attributed to the formation of ionic complexes between
the anionic hGH and cationic PAEU hydrogels and the smaller
interconnected pores in the hydrogel.75

5. LDHs scaﬀolds in soft tissue
engineering
LDHs are biocompatible inorganic biomaterials that have
enhanced thermal stability and mechanical strength of the
scaﬀolds. Monika et al. fabricated LDH-PVC nanocomposite
scaﬀolds seeded by C3H10t1/2 cells. The hemolysis test showed
a positive eﬀect and more blood compatibility on LDHsfunctionalized PVC scaﬀolds than the PVC scaﬀolds.75 Lee
et al. developed a new LDHs/polypeptide thermogel-based
nanocomposite system (Fig. 7). RGD-coated LDHs and cartogen (KGN) in poly(ethylene glycol)-poly(L-alanine)-poly(Laspartate) (PEG-PA-PD) triblock copolymer, network were used.
This combination with tonsil-derived mesenchymal stem cells
(TMSCs) was proposed as an injectable scaﬀold for chondrogenic diﬀerentiation. TMSCs in PAG-PA-PD scaﬀold with Mg–Al
LDHs retained a signicant increase in mRNA and protein
levels of type II collagen and SOX9.76
Giriprasath et al. developed a novel double-layer scaﬀold
made of HAp pellets coated by poly(3-hydroxybutyric acid)poly(N-vinylpyrrolidone) matrix and LDHs (HAp: NFM-LDHs).
The nanobrous bone gra's in vitro biocompatibility, and

Fig. 7 2D/3D nanocomposite platform incorporating stem cells,
kartogenin (KGN), and RGD-coated LDHs in a poly(ethylene glycol)poly(L-alanine)-poly(L-aspartate) (PEG-PA-PD) triblock copolymer
thermogel for eﬀective chondrogenic diﬀerentiation of the stem cells.
This ﬁgure is reproduced from ref. 76 with permission from American
Chemical Society, copyright 2017.
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uorescent activity were examined for 1, 3, 7, and 14 days. MG63
cells showed outstanding cell adhesion and proliferation on
both the top and bottom layers of the scaﬀolds. The nanobrous matrix resulted in signicantly higher cell adhesion
from day 3 to 14. Compared to the control of LDHs in the
structure, cell adhesion increased signicantly on HAp: NFMLDHs surface. This approach provides the opportunity to
perform alternative nanobrous bone gras containing Mg–Al
LDHs for bone tissue engineering applications.77 Hsiao et al.
indicated the possibility that an injectable and thermoresponsive hydrogel would be suitable for gene therapy by using
osteoarthritic chondrocytes. They formulated poly(N-isopropylacrylamide) (pNIPAAM) hydrogels with Mg–Al or Mg–Fe
LDHs by encapsulating siRNA and providing 80–95% siRNA
transfection in PNIPAAM/LDHs hybrid hydrogels. Expressions
of ACAN, MMP13, Col2A1 genes have been observed. Hydrogels
in blend with LDHs may be good candidates specifying both cell
delivery and siRNA transfection.78
Seyedeh et al. have created a new ber-based biomaterial
that can mimic ECM in tissue organ development and regeneration. They combined samples with Mg–Al LDHs ranging
from 0.1 wt% to 10 wt% in in vitro experiments with stem cells
derived from mouse adipose (mADSCs). They also assessed the
eﬀects of mADSCs on adhesion, proliferation, and viability, and
adipogenic diﬀerentiation throughout PCL enrichment with
Mg–Al LDHs. The composite electrospun PCL scaﬀolds had
a better cell adhesion and proliferation compared to nontreated PCL. Additionally, a substantial increase in the adipogenic diﬀerentiation of mADSCs was obtained. The PCL-LDHs
scaﬀolds with high porosity (94%) indicated numerous possibilities in applying so tissue engineering.79
Due to the complication of the corneal stroma ultrastructure,
eﬃcient ECM production is exceptionally challenging. Mojgan
et al. have created a new poly(urethane-urea) (PUU) based
scaﬀold that can be used in corneal tissue engineering. Zn–Al
LDHs were synthesized using the co-precipitation method,
laden with vitamin C (VC), and dispersed in the PUU to control
VC release. The scaﬀolds were prepared with electrospinning to
mimic the corneal stroma. VC-loaded Zn–Al LDHs allowed the
adhesion of the corneal regeneration. According to the in vitro
eﬀects of three types of experimental groups (PUU, PUU/Zn–Al
LDHs, and PUU/VC/Zn–Al LDHs), stromal keratocyte cells
exhibited some level of proliferation on the scaﬀolds through
the peak value obtained with PUU/VC/Zn–Al LDHs scaﬀolds
aer one week. The results showed signicant diﬀerences in
gene expression. A specic increase was observed in the
expression of ALDH3A1 protein, the keratocyte marker, and the
expression of ACTA2 gene a-SMA protein of the myobroblast
phenotype, the sustained release of VC from PUU/VC/Zn–Al
LDHs scaﬀolds. All results suggest that PUU/VC/Zn–Al LDHs
scaﬀolds may be ideal for corneal stromal tissue engineering.80

6. Future trends and perspectives
LDHs are successful candidates for carrying therapeutic agents
due to their high anion exchange capacities and charge densities for next-generation tissue engineering applications. The
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advantages such as biocompatibility, biodegradability,
tunability, and high loading eﬃciency of LDH-based drug
carriers make this eld of study a high priority range and its
expansion to other biomedical applications. LDHs contribute to
drug release mechanisms via a pH-sensitive response, wellregulated particle size, and interlayer spaces. They promise to
overcome low bioavailability, improve the thermal and photostability, and sustain and control the release of the active drug,
thereby improving their pharmacokinetics and pharmacodynamics. By increasing the eﬀectiveness of the drug, they could
reduce the dose of administration as well as reducing the side
eﬀects of current pharmaceutical drugs.
Stimuli-responsive nanomaterials have been developed for
delivering the drug to tumors. In the tumor hypoxic environment LDHs react with H2O2, this leads to a change in their
structure and then the release of the drug improving the therapeutic eﬃcacy. In the future, LDHs enhanced with nanoparticles could potentially be used in a lower pH medium for
faster and accurate tumor target drug delivery. Despite the
increase of LDHs applications in cancer research, it is still
required to understand LDHs and cells' interaction mechanisms fully. Further studies are required for understanding the
activation of the intracellular pathways of the cancer cells and
tumor cell apoptosis with the help of the LDHs. Moreover,
proteins and antigens could be delivered by LDH nano-vaccines
for cancer immunotherapy and to enhance the immune system
overall. Another major highlight of the LDHs is their eﬃcacy in
delivering genes to the target site. They have been shown
capable of transporting DNA and RNA avoiding non-specic
sites, some authors suggest that LDHs could be used for
transfection methods. Also, organic molecules such as
hormones and vitamins can be loaded into the LDHs for
controlled release.
Many challenges still exist for LDHs to evolve as a drug
delivery system of choice. While the thermosensitive LDHs can
be used for anti-HIV drug delivery in the vagina tract, the
positively charged LDHs can be a strategy for ocular drug
delivery, and its pH-dependent degradation can be a better
approach for tumor-targeted drug delivery; the sensitivity of
LDHs in an acidic environment is a hurdle in oral drug delivery
due to the enzymatic and acidic degradation in the stomach and
less absorption from the small intestine, this could be prevented by using polymer coating or other encapsulation
methods. Moreover, when administered via the blood system
they may interact with negatively charge biomolecules in the
environment that may lead to loss of surface charge, aggregation, and precipitation, thus, improvement of the LDHs stability
is a major challenge. Despite the advances in the modication
or functionalization of the surface of the LDHs for major
stability, there are a few reports in drug delivery applications.
Further studies are required to understand the in vivo biodegradability and clearance of LDHs nanomaterials and to include
development of ultra-thin LDH nanosheets to avoid pre-mature
therapeutic agents release and controlled drug release.
LDHs have been used as composites for regenerative medicine and tissue engineering applications. Herewith, LDHs can
create a bio-safe environment around cells and tissue surfaces.
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It is expected that tissue scaﬀolds should be mimicked like ECM
for cell adhesion, intercellular interaction, and cell diﬀerentiation during tissue repairing. The absence of infection is
essential to accelerate the tissue regeneration in these tissue
implants. Thus, the scaﬀolds' mechanical properties can be
tuned by using LDHs to obtain a favorable environment as
successful implants with the antibacterial properties of LDHs.
Moreover, in bone therapy and regeneration, the release of Mg+2
ions from Mg–Al LDHs, provides an alkaline environment
formation and activation of osteogenic diﬀerentiation pathways. Furthermore, Mg–Al LDHs can also induce ALP activation
of osteoblasts. In the future, to develop the best commercialization for LDHs-based biomaterials in clinic, it is necessary to
improve the surface modication, the drug loading, and the
synthesis methods to produce highly stable and uniform LHDs
with minimal variation in size, geometry, and thickness.
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